146 related articles for article (PubMed ID: 11186150)
1. Antigenicity and immunogenicity of an intracellular delivery system of major histocompatibility complex class I epitopes that bypasses proteasome processing.
Tirosh B; Fridkin M; Tzehoval E; Vadai E; Lemonnier FA; Eisenbach L
J Immunother; 2000; 23(6):622-30. PubMed ID: 11186150
[TBL] [Abstract][Full Text] [Related]
2. The requirement for proteasome activity class I major histocompatibility complex antigen presentation is dictated by the length of preprocessed antigen.
Yang B; Hahn YS; Hahn CS; Braciale TJ
J Exp Med; 1996 Apr; 183(4):1545-52. PubMed ID: 8666912
[TBL] [Abstract][Full Text] [Related]
3. Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol.
Luckey CJ; King GM; Marto JA; Venketeswaran S; Maier BF; Crotzer VL; Colella TA; Shabanowitz J; Hunt DF; Engelhard VH
J Immunol; 1998 Jul; 161(1):112-21. PubMed ID: 9647214
[TBL] [Abstract][Full Text] [Related]
4. The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules.
Bai A; Forman J
J Immunol; 1997 Sep; 159(5):2139-46. PubMed ID: 9278300
[TBL] [Abstract][Full Text] [Related]
5. Intracellular delivery of a cytolytic T-lymphocyte epitope peptide by pertussis toxin to major histocompatibility complex class I without involvement of the cytosolic class I antigen processing pathway.
Carbonetti NH; Irish TJ; Chen CH; O'Connell CB; Hadley GA; McNamara U; Tuskan RG; Lewis GK
Infect Immun; 1999 Feb; 67(2):602-7. PubMed ID: 9916065
[TBL] [Abstract][Full Text] [Related]
6. Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28.
van Hall T ; Sijts A; Camps M; Offringa R; Melief C; Kloetzel PM; Ossendorp F
J Exp Med; 2000 Aug; 192(4):483-94. PubMed ID: 10952718
[TBL] [Abstract][Full Text] [Related]
7. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.
López D; Gil-Torregrosa BC; Bergmann C; Del Val M
J Immunol; 2000 May; 164(10):5070-7. PubMed ID: 10799863
[TBL] [Abstract][Full Text] [Related]
8. Post-proteasomal antigen processing for major histocompatibility complex class I presentation.
Rock KL; York IA; Goldberg AL
Nat Immunol; 2004 Jul; 5(7):670-7. PubMed ID: 15224092
[TBL] [Abstract][Full Text] [Related]
9. Efficient delivery of Antennapedia homeodomain fused to CTL epitope with liposomes into dendritic cells results in the activation of CD8+ T cells.
Chikh GG; Kong S; Bally MB; Meunier JC; Schutze-Redelmeier MP
J Immunol; 2001 Dec; 167(11):6462-70. PubMed ID: 11714813
[TBL] [Abstract][Full Text] [Related]
10. Proteasome inhibitors reconstitute the presentation of cytotoxic T-cell epitopes in Epstein-Barr virus-associated tumors.
Gavioli R; Vertuani S; Masucci MG
Int J Cancer; 2002 Oct; 101(6):532-8. PubMed ID: 12237893
[TBL] [Abstract][Full Text] [Related]
11. Liposomal delivery of CTL epitopes to dendritic cells.
Chikh G; Schutze-Redelmeier MP
Biosci Rep; 2002 Apr; 22(2):339-53. PubMed ID: 12428909
[TBL] [Abstract][Full Text] [Related]
12. Introduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila antennapedia homeodomain primes cytotoxic T cells in vivo.
Schutze-Redelmeier MP; Gournier H; Garcia-Pons F; Moussa M; Joliot AH; Volovitch M; Prochiantz A; Lemonnier FA
J Immunol; 1996 Jul; 157(2):650-5. PubMed ID: 8752913
[TBL] [Abstract][Full Text] [Related]
13. Induction of antitumor immunity by proteasome-inhibited syngeneic fibroblasts pulsed with a modified TAA peptide.
El-Shami KM; Tirosh B; Popovic D; Carmon L; Tzehoval E; Vadai E; Feldman M; Eisenbach L
Int J Cancer; 2000 Jan; 85(2):236-42. PubMed ID: 10629083
[TBL] [Abstract][Full Text] [Related]
14. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses.
Schwarz K; de Giuli R; Schmidtke G; Kostka S; van den Broek M; Kim KB; Crews CM; Kraft R; Groettrup M
J Immunol; 2000 Jun; 164(12):6147-57. PubMed ID: 10843664
[TBL] [Abstract][Full Text] [Related]
15. Heat shock protein-chaperoned peptides but not free peptides introduced into the cytosol are presented efficiently by major histocompatibility complex I molecules.
Binder RJ; Blachere NE; Srivastava PK
J Biol Chem; 2001 May; 276(20):17163-71. PubMed ID: 11278929
[TBL] [Abstract][Full Text] [Related]
16. Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8(+) T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway.
Lautscham G; Mayrhofer S; Taylor G; Haigh T; Leese A; Rickinson A; Blake N
J Exp Med; 2001 Oct; 194(8):1053-68. PubMed ID: 11602636
[TBL] [Abstract][Full Text] [Related]
17. PI31 is a modulator of proteasome formation and antigen processing.
Zaiss DM; Standera S; Kloetzel PM; Sijts AJ
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14344-9. PubMed ID: 12374861
[TBL] [Abstract][Full Text] [Related]
18. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules.
Niedermann G; Butz S; Ihlenfeldt HG; Grimm R; Lucchiari M; Hoschützky H; Jung G; Maier B; Eichmann K
Immunity; 1995 Mar; 2(3):289-99. PubMed ID: 7535183
[TBL] [Abstract][Full Text] [Related]
19. The role of the ubiquitin-proteasome pathway in MHC class I antigen processing: implications for vaccine design.
Sijts A; Zaiss D; Kloetzel PM
Curr Mol Med; 2001 Dec; 1(6):665-76. PubMed ID: 11899255
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic T lymphocyte epitopes of HIV-1 Nef: Generation of multiple definitive major histocompatibility complex class I ligands by proteasomes.
Lucchiari-Hartz M; van Endert PM; Lauvau G; Maier R; Meyerhans A; Mann D; Eichmann K; Niedermann G
J Exp Med; 2000 Jan; 191(2):239-52. PubMed ID: 10637269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
